The Food and Drug Administration sent warning letters to dozens of drug companies— including popular telehealth firm Hims & Hers and pharmaceutical giants Eli Lilly and Novo Nordisk— demanding the
The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro (tirzepatide), both produced by Eli Lilly And Co. LLY, is false or misleading.
Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid the Trump administration tariff threats on drug imports.
Eli Lilly's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.
Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments — the
CNBC's Angelica Peebles reports on news regarding Eli Lilly.
Plan is part of the drugmaker's pledge to bolster its domestic medicine production with four new pharmaceutical manufacturing sites.
Eli Lilly said on Tuesday it will invest $5 billion to build a manufacturing facility in Virginia, the first of four new U.S. plants the drugmaker has planned as it moves to expand domestic production
Eli Lilly & Co. CEO Dave Ricks says the U.K. has gone from biopharmaceutical leader to laggard. Lilly is among a handful of biopharma companies that have put investments in the U.K. on hold amid conce
Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments. The pla
New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other advanced therapies Company will create 2,450 high-wage manufac
Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.
The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (LLY -0.96%) and Novo Nordisk (NVO 1.39%), and opened the door for companies such as
Eli Lilly shares move past the 50-day SMA as weight-loss drug data, rising sales and pipeline momentum fuel optimism.
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE